Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opioid Receptors in Immune and Glial Cells—Implications for Pain Control
Halina Machelska, Melih Ö. Celik
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain
János Tajti, Délia Szok, Anett Csáti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4114-4114
Open Access | Times Cited: 56
Unlocking opioid neuropeptide dynamics with genetically encoded biosensors
Chunyang Dong, Raajaram Gowrishankar, Yihan Jin, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 9, pp. 1844-1857
Open Access | Times Cited: 18
Microglia in neuroimmunopharmacology and drug addiction
Hongyuan Li, Linda R. Watkins, Xiaohui Wang
Molecular Psychiatry (2024) Vol. 29, Iss. 6, pp. 1912-1924
Closed Access | Times Cited: 16
A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System
Mario García‐Domínguez
Biomedicines (2025) Vol. 13, Iss. 1, pp. 165-165
Open Access | Times Cited: 2
Morphine's role in macrophage polarization: Exploring M1 and M2 dynamics and disease susceptibility
Jonaid Ahmad Malik, Javed N. Agrewala
Journal of Neuroimmunology (2025) Vol. 400, pp. 578534-578534
Closed Access | Times Cited: 2
Pain Biomarkers in Fibromyalgia Syndrome: Current Understanding and Future Directions
Martina Favretti, Cristina Iannuccelli, Manuela Di Franco
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10443-10443
Open Access | Times Cited: 26
Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain
János Tajti, Délia Szok, Anett Csáti, et al.
(2023)
Open Access | Times Cited: 25
The mechanistic basis for the effects of electroacupuncture on neuropathic pain within the central nervous system
Zhou Mengmeng, Qingxiang Zhang, Mingzhu Huo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114516-114516
Open Access | Times Cited: 23
The psychophysiology of music-based interventions and the experience of pain
Carolyn Arnold, Matthew K. Bagg, Alan R. Harvey
Frontiers in Psychology (2024) Vol. 15
Open Access | Times Cited: 10
Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Li Zhang, Jiangtao Zhang, Lihua Hang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 57
Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain—Narrative Review
Magdalena Kocot-Kępska, Renata Zajączkowska, Joanna Mika, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 450-450
Open Access | Times Cited: 45
The Interplay between Chronic Pain, Opioids, and the Immune System
Valentina Malafoglia, Sara Ilari, Laura Vitiello, et al.
The Neuroscientist (2021) Vol. 28, Iss. 6, pp. 613-627
Open Access | Times Cited: 44
Peripheral Mechanisms of Neuropathic Pain—The Role of Neuronal and Non-Neuronal Interactions and Their Implications for Topical Treatment of Neuropathic Pain
Magdalena Kocot-Kępska, Renata Zajączkowska, Joanna Mika, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 77-77
Open Access | Times Cited: 43
Astrocytic Calcium and cAMP in Neurodegenerative Diseases
Marta Sobolczyk, Tomasz Boczek
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 29
Neuroimmune Mechanisms of Opioid Use Disorder and Recovery: Translatability to Human Studies, and Future Research Directions
Eduardo R. Butelman, Rita Z. Goldstein, Chinwe A. Nwaneshiudu, et al.
Neuroscience (2023) Vol. 528, pp. 102-116
Open Access | Times Cited: 21
Single nucleus transcriptomics of ventral midbrain identifies glial activation associated with chronic opioid use disorder
Julong Wei, Tova Y. Lambert, Aditi Valada, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 7
Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
Mervin Chávez-Castillo, Ángel Ortega, Lorena Cudris–Torres, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10370-10370
Open Access | Times Cited: 36
Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors
Jolien De Neve, Thomas Barlow, Dirk Tourwé, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 6, pp. 828-870
Open Access | Times Cited: 35
The role of opioids in cancer response to immunotherapy
Andrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 34
Glycometabolism Reprogramming of Glial Cells in Central Nervous System: Novel Target for Neuropathic Pain
Erliang Kong, Yongchang Li, Mengqiu Deng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Opioids Regulate the Immune System: Focusing on Macrophages and Their Organelles
Shaohua Wen, Yuan Jiang, Shuang Liang, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 23
Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis
David G. Lambert
BJA Open (2023) Vol. 6, pp. 100141-100141
Open Access | Times Cited: 16
Focal mu‐opioid receptor activation promotes neuroinflammation and microglial activation in the mesocorticolimbic system: Alterations induced by inflammatory pain
Javier Cuitavi, Paula Andrés‐Herrera, D. Meseguer, et al.
Glia (2023) Vol. 71, Iss. 8, pp. 1906-1920
Open Access | Times Cited: 15
Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment
Hélène Cabanas, Katsuhiko Muraki, Natalie Eaton-Fitch, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top